Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Delavirdine Mesylate

Known as: Delavirdine Mesylate [Chemical/Ingredient], Mesylate, Delavirdine 
A mesylate salt form of delavirdine, a synthetic, non-nucleoside reverse transcriptase inhibitor. In combination with other anti-retroviral drugs… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
  • P. Gao
  • Pharmaceutical Research
  • 2004
  • Corpus ID: 6122113
AbstractPurpose. The application of solid-state nuclear magnetic resonance for the quantitation of relative amounts of… Expand
Review
2002
Review
2002
Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. A few examples of well-documented clinically significant… Expand
  • table 1
  • table 2
  • table 3
  • table 4
1999
1999
To evaluate the antiretroviral activity of delavirdine mesylate, a non-nucleoside reverse transcriptase inhibitor of HIV-1, we… Expand
Highly Cited
1998
Highly Cited
1998
Administration of delavirdine, an HIV-1 reverse transcriptase inhibitor, to rats or monkeys resulted in apparent loss of hepatic… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
1998
1998
The potential pharmacokinetic drug-drug interaction between delavirdine, a nonnucleoside analogue reverse transcriptase inhibitor… Expand
Highly Cited
1997
Highly Cited
1997
To study the effect of rifampin (INN, rifampicin), a potent inducer of cytochrome P450, on the steady‐state pharmacokinetics of… Expand
Highly Cited
1997
Highly Cited
1997
  • C. Cheng, D E Smith, +7 authors P. Stetson
  • Clinical pharmacology and therapeutics
  • 1997
  • Corpus ID: 34122850
The steady‐state kinetics of delavirdine and desisopropyldelavirdine were evaluated in human immunodeficiency virus‐positive… Expand
1997
1997
Delavirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
1997
1997
The oxidative metabolism of delavirdine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, is mediated in part by… Expand
Review
1996
Review
1996
  • W. Freimuth
  • Advances in experimental medicine and biology
  • 1996
  • Corpus ID: 44512677
In summary, DLV has been well-tolerated in > 1,000 HIV-1 infected patients. Skin rash is the most prevalent medical event… Expand